Neo-Adjuvant Bladder Urothelial Carcinoma COmbination-immunotherapy
Clinical trial NCT03387761 · COMPLETED
Trial details
- NCT number
- NCT03387761
- Sponsor
- The Netherlands Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-15
- Primary completion
- 2021-07-19
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.